Increased Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in FSGS: A Meta-Analysis

INTRODUCTION: The soluble urokinase-type plasminogen activator receptor (suPAR) has been found to be elevated in primary focal segmental glomerulosclerosis (pFSGS). However, its usefulness as a biomarker for FSGS remains controversial. We conducted a meta-analysis aiming at investigating the signifi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunol Res
Autors principals: Lee, Jiwon M., Yang, Jae Won, Kronbichler, Andreas, Eisenhut, Michael, Kim, Gaeun, Lee, Keum Hwa, Shin, Jae Il
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6476117/
https://ncbi.nlm.nih.gov/pubmed/31089477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5679518
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars